Pliant Therapeutics (PLRX)
NASDAQ:PLRX
Want to see PLRX full AI Analyst Report?
PLRX Analyst Ratings
Hold
1 Buy
4 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
PLRX Stock 12 Month Forecast
Average Price Target
$2.67
▲(100.50% Upside)
| Highest Price Target$3.00 | Average Price Target$2.67 | Lowest Price Target$2.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Piper Sandler
$3
Buy
125.56%
Upside
Reiterated
05/12/26
Canaccord Genuity
$3
Hold
125.56%
Upside
Reiterated
05/12/26
Needham
―
Hold
―
Reiterated
05/12/26
RBC Capital
$2
Hold
50.38%
Upside
Reiterated
05/11/26
J.P. Morgan
―
Sell
―
Reiterated
12/04/25
Citi
$1.5→$1.7
Hold
27.82%
Upside
Reiterated
08/11/25
Jefferies
$2
Hold
50.38%
Upside
Reiterated
08/07/25
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Piper Sandler
$3
Buy
125.56%
Upside
Reiterated
05/12/26
Canaccord Genuity
$3
Hold
125.56%
Upside
Reiterated
05/12/26
Needham
―
Hold
―
Reiterated
05/12/26
RBC Capital
$2
Hold
50.38%
Upside
Reiterated
05/11/26
J.P. Morgan
―
Sell
―
Reiterated
12/04/25
Citi
$1.5→$1.7
Hold
27.82%
Upside
Reiterated
08/11/25
Jefferies
$2
Hold
50.38%
Upside
Reiterated
08/07/25
Best Analysts Covering Pliant Therapeutics
3 Months
Success Rate
6/13 ratings generated profit
Average Return
-6.76%
Copying Yasmeen Rahimi's trades and holding each position for 3 Months would result in 46.15% of your transactions generating a profit, with an average return of -6.76% per trade.
1 Year
Success Rate
1/13 ratings generated profit
Average Return
-47.28%
Copying Yasmeen Rahimi's trades and holding each position for 1 Year would result in 7.69% of your transactions generating a profit, with an average return of -47.28% per trade.
2 Years
Success Rate
0/13 ratings generated profit
Average Return
-65.81%
Copying Yasmeen Rahimi's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -65.81% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
PLRX Analyst Recommendation Trends
Rating
Jan 26
Feb 26
Mar 26
Apr 26
May 26
Strong Buy
0
0
2
2
3
Buy
0
0
0
0
0
Hold
3
1
4
4
7
Sell
1
1
0
0
0
Strong Sell
0
0
0
0
0
total
4
2
6
6
10
Each month's total comprises the sum of three months' worth of ratings.
PLRX Financial Forecast
PLRX Stock Forecast FAQ
What is PLRX’s average 12-month price target, according to analysts?
Based on analyst ratings, Pliant Therapeutics’s 12-month average price target is 2.67.
What is PLRX’s upside potential, based on the analysts’ average price target?
Pliant Therapeutics has 100.50% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is PLRX a Buy, Sell or Hold?
Pliant Therapeutics has a consensus rating of Hold which is based on 1 buy ratings, 4 hold ratings and 0 sell ratings.
What is Pliant Therapeutics’s price target?
The average price target for Pliant Therapeutics is 2.67. This is based on 5 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $3.00 ,the lowest forecast is $2.00. The average price target represents 100.50% Increase from the current price of $1.33.
The highest analyst price target is $3.00 ,the lowest forecast is $2.00. The average price target represents 100.50% Increase from the current price of $1.33.
What do analysts say about Pliant Therapeutics?
Pliant Therapeutics’s analyst rating consensus is a Hold. This is based on the ratings of 5 Wall Streets Analysts.
How can I buy shares of PLRX?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.